Building Life With Generative AI
SMRTR summary
Generative AI is being applied to life sciences, enabling precise protein engineering and antibody discovery. Flagship Pioneering's Geoff von Maltzahn explains how AI models can create improved antibodies for diseases like cancer and potentially develop longer-lasting protection against future pandemics, with vast potential for exploring unexplored biology.
SMRTR provides this summary for quick context. The original article belongs to Forbes.
Read the original article